NCT03480529 - Monitoring the IMmUological TOXicity of Drugs | Biotech Hunter

Enrollment

662

Participants

Timeline

Start Date

March 1, 2018

Primary Completion Date

March 10, 2018

Study Completion Date

March 10, 2018

Conditions

ArthritisSystemic Lupus ErythematosusRheumatoid ArthritisCapillary Leak SyndromeHepatitis

Interventions

DRUG

drug inducing arthritis, lupus, hepatitis, or capillary leak syndrom

Drugs susceptible to induce arthritis, lupus, hepatitis, or capillary leak syndrom

Trial Locations (2)

Rhumatology department, CHU Strasbourg, Hautepierre hospital, Strasbourg

AP-HP, Pitié-Salpêtrière Hospital, Department of Pharmacology, CIC-1421, Pharmacovigilance Unit, INSERM., Paris

All Listed Sponsors

collaborator

Institut National de la Santé Et de la Recherche Médicale, France

OTHER_GOV

lead

Groupe Hospitalier Pitie-Salpetriere

OTHER